The present invention refers to the use of peptides of sequence Met-Gln-Cys-Asn-Ser- monocyte locomotion inhibitory factor [MQCNS (MILF)]; which is derived from Entamoeba histolytica, as a neuroprotector and immunomodulator in the treatment of spine cord injuries.
展开▼